Artificial Intelligence Dopavision | Developing a Digital Therapeutic for Myopia


Enterprise, Medical Devices, Digital Health, Therapeutic, Ophthalmologist Diagnostics Berlin , Germany

Dopavision

Artificial Intelligence


Dopavision | Developing a Digital Therapeutic for Myopia

Dopavision

Medical Devices, Digital Health, Therapeutic, Ophthalmologist Diagnostics


Berlin , Germany

We are a team of entrepreneurs, scientists, researchers and tech developers who are all passionate about bringing innovation in digital health to patients. We have built Dopavision to develop breakthrough digital healthcare solutions, combining scientific and technical curiosity with the goal of creating significant benefits for patients. Our offices are located in the heart of Berlin.

Myopia, or shortsightedness, is a condition where the visual image is focused in front of the retina, instead of on the retina itself, as it should. People with myopia have good near sight vision but poor distance vision. Dopavision is developing a digital therapeutic for myopia which can be seamlessly and invisibly integrated with the use of a smartphone. Myopia is a visual condition that affects on average every third person globally, a share that has increased rapidly during the last two decades. It has grown to alarming proportions in Asia where prevalence rates, e.g., in Singapore, have reached 80% among young adults. High myopia imposes a significant risk to cause visual impairment and even blindness later in life.

 
 

   Total Funding: €13,200,000

   Funding Stage: Series A

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 1 to 25

   Founded: 2017

 
 

Date

Round

$ Raised

Investors

07/14/2021

Series A

$14.1M

Seventure Partners, Novartis Pharmaceuticals, Boehringer Ingelheim Venture Fund, Ababax Health

Date : 07/14/2021

Round: Series A

$ Raised: $14.1M

Investors: Seventure Partners, Novartis Pharmaceuticals, Boehringer Ingelheim Venture Fund, Ababax Health

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Dopavision

 
 
 
Hamed Bahmani


Hamed Bahmani
Founder and Managing Director

Stefan Zundel


Stefan Zundel
Co-founder & Managing Director

Andreas Balser


Andreas Balser
CTO

Imane Wild


Imane Wild
Chief Medical Officer

 
 

Dopavision is growing. Want to work at Dopavision? Dopavision is hiring. Join team at Dopavision

 

View All

Product Manager (m/f/x)

Berlin, Berlin

 
 
appengine.ai

World's Most Promising AI/ML Startups